05:01 PM EDT, 07/24/2024 (MT Newswires) -- Edwards Lifesciences ( EW ) said late Wednesday it struck a deal to acquire JenaValve Technology and exercised its option to buy Endotronix in a bid to expand its structural heart portfolio.

Edwards Lifesciences ( EW ) said its decision to exercise its option for Endotronix follows an investment made in the business in 2016.

The total upfront purchase price for the investments is about $1.2 billion, the company said, adding that it expects "minimal" revenue contribution from the acquisitions next year.

Price: 75.00, Change: -11.95, Percent Change: -13.74